Skip to main content
. 2018 Apr 20;9(30):21281–21288. doi: 10.18632/oncotarget.25086

Figure 2. ROC curve analysis of diagnostic sensitivity and specificity of using ALU repeat ratios.

Figure 2

(A) – all lung cancer vs controls, AUC – 0.61, p = 0.22; (B) – advanced cases vs controls, AUC – 0.88, p=0.0077; (C) – Early stage vs controls, AUC 0.67, P=0.23; (D) – advanced cases vs early stage, AUC – 0.92, P=0.0002.